Clinical trial

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected…

NCT00307151 · International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Other · Completed

Key facts

NCT number NCT00307151
Title Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
Official title Phase II, Parallel, Randomized, Clinical Trials Comparing the Responses to Initiation of NNRTI-Based Versus PI-Based Antiretroviral Therapy in HIV Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mother-to-Child HIV Transmission
Acronym P1060
Lead sponsor International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Other
Collaborators National Institute of Allergy and Infectious Diseases (NIAID) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Status Completed
Phase Phase 2
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Lamivudine, Lopinavir/ritonavir, Nevirapine, Zidovudine
Enrollment 452
Start date Dec 1, 2005
Primary completion Dec 1, 2010
Completion Dec 1, 2016
First posted Mar 27, 2006
Last update posted Apr 13, 2017
Countries India, Malawi, South Africa, Tanzania, Uganda, Zambia, Zimbabwe

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies